Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

2
RTL names new head of Fremantle production unit

2018-07-26 reuters
FRANKFURT, July 26 (Reuters) - European broadcaster RTL Group said on Thursday it had appointed Jennifer Mullin as the new head of its FremantleMedia production unit, replacing Cecile Frot-Coutaz who is leaving to join YouTube.
FOX RTL RGLXY RGLXF FOXA

6
RPT-Content-hungry bidders circle 'Big Brother' maker Endemol

2018-07-05 reuters
FRANKFURT/LONDON, July 4 (Reuters) - Several bidders, including Liberty Global, are preparing offers for TV production company Endemol Shine, maker of classic reality show ‘Big Brother’ and the dystopian ‘Black Mirror’ dramas, before an initial deadline next week.
FOX LGF LBTY LBTYB RGLXY LBTYA LBTYK LILAB LILAK RTL LGF.A LGF.B RGLXF FOXA LILA

7
Content-hungry bidders circle 'Big Brother' maker Endemol

2018-07-04 reuters - 1
FRANKFURT/LONDON (Reuters) - Several bidders, including Liberty Global, are preparing offers for TV production company Endemol Shine, maker of classic reality show ‘Big Brother’ and the dystopian ‘Black Mirror’ dramas, before an initial deadline next week.
FOX LGF LBTY LBTYB RGLXY LBTYA LBTYK LILAB LILAK RTL LGF.A LGF.B RGLXF FOXA LILA

6
Content-hungry bidders circle 'Big Brother' maker Endemol - Channel NewsAsia

2018-07-04 channelnewsasia
Several bidders, including Liberty Global, are preparing offers for TV production company Endemol Shine, maker of classic reality show 'Big Brother' and the dystopian 'Black Mirror' dramas, before an initial deadline next week.
FOX LGF LBTY LBTYB RGLXY LBTYA LBTYK LILAB LILAK RTL LGF.A LGF.B RGLXF FOXA LILA

22
European TV Gets Ready to Fight Off Netflix and HBO - Bloomberg

2018-06-06 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
TWX RTL RGLXY NFLX RGLXF TWC DIS

6
Has Netflix Killed Off Linear TV? This CEO is About to Find Out - Bloomberg

2018-06-01 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
RTL RGLXY NFLX RGLXF

Related Articles

REPH: Recro Pharma Analysis and Research Report

2018-08-20 - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

2018-08-20 - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

2018-08-20 - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...